DSM Pushes Back Schedule for Some Planned Divestments

DSM’s Feike Sijbesma this morning told CW that the company continues to be “on track” regarding the previously disclosed plan to divest its antibiotics businesses but that it will delay the planned sale of some of its other businesses, including fertilizers, melamine, and elastomers. DSM is delaying the sell off process for some divestment targets in order to give investors time to arrange financing in light of the scarcity of available capital, Sijbesma says. "We are delaying the timing of the sell offs a little bit,” Sijbesma says...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers